Your browser is no longer supported. Please, upgrade your browser.
MACK [NASD]
Merrimack Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.23 Insider Own0.35% Shs Outstand13.41M Perf Week3.42%
Market Cap57.30M Forward P/E- EPS next Y- Insider Trans311.55% Shs Float13.36M Perf Month13.25%
Income-3.10M PEG- EPS next Q- Inst Own62.50% Short Float3.30% Perf Quarter-1.95%
Sales- P/S- EPS this Y85.80% Inst Trans-0.05% Short Ratio15.54 Perf Half Y-26.82%
Book/sh1.09 P/B4.16 EPS next Y- ROA-19.20% Target Price4.00 Perf Year-40.08%
Cash/sh1.15 P/C3.92 EPS next 5Y5.60% ROE-20.10% 52W Range3.66 - 9.45 Perf YTD15.86%
Dividend- P/FCF- EPS past 5Y55.90% ROI- 52W High-52.06% Beta2.05
Dividend %- Quick Ratio22.20 Sales past 5Y- Gross Margin- 52W Low23.77% ATR0.30
Employees- Current Ratio22.20 Sales Q/Q- Oper. Margin- RSI (14)57.90 Volatility9.57% 6.62%
OptionableYes Debt/Eq0.00 EPS Q/Q47.90% Profit Margin- Rel Volume1.27 Prev Close4.94
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume28.36K Price4.53
Recom3.50 SMA2010.74% SMA509.14% SMA200-14.26% Volume35,900 Change-8.30%
Oct-07-16Downgrade JP Morgan Overweight → Neutral
May-27-16Initiated Robert W. Baird Neutral $8
Dec-23-15Reiterated Mizuho Buy $16 → $13
Oct-27-15Reiterated Oppenheimer Outperform $13 → $15
Apr-21-15Reiterated Mizuho Buy $13 → $16
Oct-10-14Resumed Oppenheimer Outperform $9 → $11
Jul-08-14Resumed Brean Capital Buy $16
Jun-20-14Reiterated Oppenheimer Outperform $10 → $8.50
Aug-09-13Reiterated Oppenheimer Outperform $12 → $10
Jun-25-13Initiated Mizuho Buy $12
May-08-12Initiated Oppenheimer Outperform $12
Dec-06-21 07:22AM  
Nov-04-21 05:00PM  
Sep-06-21 09:50AM  
Aug-05-21 04:30PM  
Jun-08-21 05:31AM  
Jun-07-21 02:10PM  
May-28-21 08:00AM  
Mar-10-21 06:00PM  
Dec-10-20 02:10AM  
Dec-03-20 07:46AM  
Nov-29-20 12:12PM  
Nov-05-20 08:20AM  
Aug-07-20 08:20AM  
Aug-05-20 08:33AM  
May-07-20 06:10PM  
Apr-02-20 08:30AM  
Feb-07-20 11:14AM  
Dec-22-19 07:44PM  
Dec-03-19 09:15AM  
08:45AM  
Oct-28-19 06:04AM  
Sep-24-19 04:45PM  
Sep-19-19 03:23PM  
09:00AM  
Aug-26-19 11:27AM  
09:00AM  
Aug-22-19 08:30AM  
Aug-16-19 09:15AM  
Jul-25-19 08:30AM  
May-31-19 07:34AM  
06:21AM  
May-30-19 04:05PM  
May-10-19 07:30AM  
May-06-19 01:46PM  
May-03-19 05:43PM  
Apr-18-19 03:07PM  
Apr-16-19 04:15PM  
Apr-12-19 01:57PM  
Apr-09-19 05:50PM  
Apr-08-19 10:12AM  
Apr-05-19 08:29AM  
07:48AM  
Apr-04-19 05:58PM  
04:15PM  
Mar-07-19 09:06AM  
Mar-06-19 07:00AM  
Feb-12-19 07:35AM  
Feb-11-19 09:39AM  
Jan-28-19 10:19PM  
Dec-10-18 05:00PM  
Nov-09-18 10:31AM  
08:45AM  
Nov-08-18 10:17AM  
Nov-07-18 06:45AM  
Nov-06-18 01:44PM  
Nov-05-18 07:55AM  
Oct-31-18 04:05PM  
Oct-24-18 11:19AM  
Oct-19-18 10:48AM  
07:46AM  
06:00AM  
Oct-16-18 07:30AM  
Oct-11-18 05:16PM  
Sep-20-18 07:00AM  
Sep-06-18 10:35AM  
06:50AM  
Sep-05-18 12:06PM  
Sep-04-18 10:07AM  
Aug-16-18 08:00AM  
Aug-08-18 10:20AM  
Aug-07-18 08:18AM  
06:30AM  
06:30AM  
Aug-01-18 12:09PM  
Jul-31-18 04:10PM  
Jul-10-18 04:55PM  
Jul-02-18 04:15PM  
Jun-27-18 08:12AM  
Jun-26-18 07:51PM  
08:12AM  
Jun-25-18 07:55AM  
07:54AM  
07:29AM  
07:20AM  
Jun-15-18 08:41AM  
Jun-07-18 09:15AM  
Jun-04-18 01:57PM  
May-29-18 08:15AM  
07:00AM  
May-09-18 10:49AM  
May-08-18 06:25AM  
May-03-18 10:13AM  
May-01-18 07:00AM  
Apr-09-18 07:30AM  
Apr-04-18 08:15AM  
Mar-14-18 07:30AM  
Mar-13-18 09:45AM  
Mar-12-18 07:06PM  
07:30AM  
06:27AM  
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CROCKER GARY LSee RemarksJan 18Buy4.545,00022,68958,731Jan 20 04:05 PM
CROCKER GARY LSee RemarksJan 14Buy4.515,00022,55453,731Jan 18 04:05 PM
CROCKER GARY LSee RemarksJan 13Buy4.425,00022,12048,731Jan 18 04:05 PM
CROCKER GARY LSee RemarksJan 12Buy4.335,00021,65843,731Jan 13 04:05 PM
CROCKER GARY LSee RemarksJan 11Buy4.035,00020,14038,731Jan 13 04:05 PM
Levy Noah G.DirectorJan 11Buy4.0091,270364,907987,118Jan 12 04:05 PM
Levy Noah G.DirectorJan 10Buy3.8314,67956,285910,576Jan 12 04:05 PM
Levy Noah G.DirectorJan 07Buy3.828,78033,524901,857Jan 10 04:05 PM
RAY RUSSELL TDirectorDec 31Sale3.841,0003,8400Jan 04 04:05 PM
Andersen EricDirectorApr 14Buy6.6347,300313,736947,396Apr 16 04:05 PM
Andersen EricDirectorApr 13Buy6.269,87461,780906,591Apr 15 04:05 PM
Andersen EricDirectorApr 12Buy6.0623,629143,194896,717Apr 14 04:05 PM
CROCKER GARY LSee RemarksApr 12Buy6.079735,90533,731Apr 14 04:05 PM
CROCKER GARY LSee RemarksApr 09Buy6.101,2007,32032,758Apr 12 04:05 PM
CROCKER GARY LSee RemarksApr 07Buy6.192,12713,16631,558Apr 09 04:05 PM
CROCKER GARY LSee RemarksMar 25Buy6.132001,22628,931Mar 26 05:46 PM
CROCKER GARY LSee RemarksMar 24Buy6.345,00031,69028,731Mar 25 05:50 PM
CROCKER GARY LSee RemarksMar 23Buy6.473,62723,45523,731Mar 25 05:50 PM
CROCKER GARY LSee RemarksMar 16Buy6.795,00033,95620,104Mar 17 05:08 PM
CROCKER GARY LSee RemarksFeb 23Buy7.205,00036,00415,104Mar 05 04:05 PM
CROCKER GARY LSee RemarksFeb 12Buy7.475,00037,34210,104Feb 17 04:05 PM
CROCKER GARY LSee RemarksFeb 11Buy7.981,60412,7985,104Feb 12 06:16 PM
CROCKER GARY LSee RemarksFeb 10Buy7.643,50026,7573,500Feb 12 06:16 PM